RxDoctor Payments Data

Sherman Alter

Pediatric Infectious Diseases · Dayton, OHNPI 1871559914

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $303,925 of the $362,542 with a category attached, or 83.8%. Every reported general payment came from a single manufacturer, GSK. Reporting peaked in 2022 at $117,158 and has fallen 94.3% since, to $6,731 in 2025. Among pediatric infectious diseases clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$362,542in general payments, 2019–2025

Across 407 payments — averaging $890.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$363K

What the payments were for

  • Speaking & faculty fees$303,92584%
  • Travel & lodging$50,30014%
  • Food & beverage$8,3172%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK407$362,542

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$362,542 in reported general payments places this provider in the 95th percentile of 43 pediatric infectious diseases providers in Ohio.

See all pediatric infectious diseases providers in Ohio →

Other pediatric infectious diseases in Dayton

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →